Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at NDORMS have developed a new set of guidelines for reporting mediation analyses in health research.

A new guideline has been developed to help scientists publish their research accurately and transparently. Published in JAMA, the AGReMA Statement (A Guideline for Reporting Mediation Analyses) provides recommendations for researchers who want to describe mediation analysis in their paper. Mediation analysis is primarily used to understand how an intervention works or why it does not.  

The checklists can be found on the AGReMA website, and the explanation and elaboration paper in JAMA explains the importance of each item and how the checklist can be used by authors, peer reviewers and journal editors. 

Hopin Lee, NHMRC Postdoctoral Research Fellow at NDORMS and lead author explained: “The use of mediation analysis has grown rapidly over the past 10 years across a wide range of disciplinesOur research has shown that their reporting has been poor and inconsistent, which makes it difficult to understand how the research was conducted and how reliable the findings are. We hope that the AGReMA statement will fix some of these issues. 

Gary Collins, director of the UK EQUATOR centre noted: “AGReMA was developed through a rigorous evidence- and consensus-based process using the EQUATOR methodological framework. We think it will be a useful tool for many researchers conducting mediation analyses of trials and observational studies.”   

Developed by an international team of methodologists, statisticians, clinical trialists, epidemiologists, psychologists, applied clinical researchers, clinicians, implementation scientists, evidence synthesis experts, representatives from the EQUATOR Network, and journal editorsthe consensus-based checklist provides detailed steps to help researchers present clear and transparent reports that will raise the standard of reporting of mediation analyses.  

AGReMA is not tied to a particular disease condition or subspecialty of medicine,” said Hopin. “Our working group will liaise with journal editors and funding agencies to increase awareness and encourage its use. Our hope is that it will be endorsed by journal editors, peer reviewers, and authors and improve the accuracy, completeness and consistency in reporting mediation analyses.”  

The development of AGReMA was supported by the Berkeley Initiative for Transparency in the Social Sciences, the Center for Effective Global Action, and the Laura and John Arnold Foundation. 

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.

Building a humanoid bioreactor

A humanoid robot is being used at NDORMS in an attempt to grow tendon tissue for repairing shoulder injuries.